Bid to limit prices on drugs using ‘public’ discoveries

Meredith Wadman

Nature, 1998, vol. 393, issue 6683, 297-297

Abstract: washington The US biotechnology industry has attacked a Congressional bill that will restrict the prices of drugs that are based on federally funded biomedical discoveries.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/30570 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:393:y:1998:i:6683:d:10.1038_30570

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/30570

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().